Transcriptomics & Multiomics CRO Services

Genes. Proteins. Cells.
Get the full picture.

Explicyte designs and runs custom multiomics workflows — single-cell and spatial transcriptomics, digital pathology and proteomics.

We then integrates the data layers into publication-ready insights on your targets, biomarkers and biological programs.

Transcriptomics & multiomics CRO services

Take a look under the hood

Video description to fill

Strategic advice

We help you choose the optimal platform, panel, and multiplexing strategy for your study goals, timelines, and budget.

Fast turnaround

We use validated strategies to reduce turnaround time and contain costs without compromising data quality.

Tailored analysis

Our data science team cleans, integrates, and interprets your data to deliver actionable insights and publication-ready figures.

Tell us about your project

Our datasets were recently published in

Molecular Cancer Research journal logoCancer Cell journal logoClinical cancer research journal logoScience Advances logoCancer Cell journal logoSignal transduction and targeted therapy journal logoNature cancer journal logoCell Reports Medicine journal logoOncoImmunologyMolecular Cancer Research journal logo
explicyte multiomics transcriptomics CRO team

Paul Marteau, PharmD (study director), Imane Nafia, PhD (CSO), Loïc Cerf, MSc (COO), Alban Bessede, PhD (founder, CEO), Jean-Philippe Guégan, PhD (CTO)

contact our team

Discuss your multiomics project and request a quote

Within 3 days, our team will arrange an online discussion to help you define the right platform, multiplexing strategy, and data analysis workflow for your study.

Answers about transcriptomics & multiomics CRO services

Frequently asked questions

What is Explicyte Multiomics, and who is it for?

Explicyte Multiomics is Explicyte’s integrated profiling and data analysis offering for cells, tissues, and biofluids. Combining transcriptomic, proteomic, digital pathology, and cellular profiling workflows, we support academic, biotech, pharma, and AI teams seeking robust multiomics datasets across oncology, immunology, neurobiology, developmental biology, and dermatology and cosmetics.

Explicyte Multiomics supports the generation, analysis, and integration of multidimensional datasets across complementary platforms, including single-cell and spatial transcriptomics, proteomics, digital pathology, and flow cytometry. Through the integration of multi-scale datasets with biological and clinical metadata, we help sponsors characterize biological systems and uncover novel therapeutic targets and biomarkers.

Yes. Explicyte Multiomics supports both publicly funded and private projects. For academic and medical teams, we generate robust, publishable datasets and can assist with manuscript preparation. For industry sponsors, we support drug discovery and translational programs from target identification through preclinical profiling and clinical biomarker analysis, delivering actionable data and scientific communication-ready materials.

We support projects on a broad range of sample types, including fresh, cryopreserved, and FFPE tissues, fixed cells, cell pellets, tissue homogenates, and biofluids. For each platform, we provide detailed sample requirements as well as storage and shipping recommendations to preserve sample quality and ensure reliable downstream analysis.

Yes. We provide secure, high-speed dataset transfer through an EU-based server. Uploaded data are handled in a protected environment and remain securely accessible at the end of the study, including raw files, quality control outputs, interactive HTML reports, and vector-format figures.

Yes. We provide secure, high-speed dataset transfer through an EU-based server. Uploaded data are handled in a protected environment and remain securely accessible at the end of the study, including raw files, quality control outputs, interactive HTML reports, and vector-format figures.

Our typical turnaround time for data analysis ranges from 1 to 4 weeks, depending on the scope and depth of analysis. Full custom analysis reports, including quality control, data cleaning, and integration with additional metadata, are typically delivered within one month.

Yes. For the past 10 years, we have supported academic and industry teams in the preparation of manuscripts, posters, and scientific communication materials. Our datasets have supported publications in leading journals, including Nature Medicine, Immunity, and Cancer Cell. Depending on the project scope, we deliver publication-ready figures, integrated analysis outputs, and Materials and Methods content.

Our projects are typically structured as fee-for-service engagements, with scope, deliverables, timelines, and usage rights defined contractually upfront. Unless otherwise agreed, clients retain full intellectual property rights to their datasets and project results, while Explicyte retains ownership of its proprietary methods and workflows.

Explicyte Oncology CRO logo

Capabilities

Modalities